Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Birmex Antiscorpion Serum vs Alacramyn for Scorpion Sting
NCT00739440Phase 4Completed
- Sponsor
- BIRMEX
- Start
- Aug 2008
- Primary completion
- Oct 2008
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 4 trial of scorpion antivenom (equine) in scorpion envenomation, sponsored by BIRMEX. Started Aug 2008; status: completed.
02
Drugs
scorpion antivenom (equine)
03
Conditions
scorpion envenomation
Beyond the preview
Go deeper on NCT00739440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00739440.